Core Laboratories N.V.
New York Stock ExchangeRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Core Laboratories N.V. (NYSE: CLB) provides proprietary and patented reservoir description, production enhancement, and reservoir management services and products to the oil and gas industry worldwide. The company offers core analysis including basic rock properties, special core analysis, digital rock characterization, and non-invasive technologies such as NITRO SM for rapid Fit-For-Reservoir TM core and fluid data; reservoir fluid characterization and PVT analysis; production enhancement solutions encompassing proppant crush testing with Complete Crush TM, hydraulic fracturing diagnostics, production logging, well spacing diagnostics using tracers, and enhanced oil recovery studies; petroleum products testing and crude oil assays; carbon capture and storage subsurface characterization; laboratory instruments, pumps, and accessories; as well as reservoir modeling, simulation, and field development planning. Core Laboratories operates through three segments—Reservoir Description, Production Enhancement, and Reservoir Management—serving major, national, and independent oil companies across more than 50 countries on six continents with over 70 offices and four advanced technology centers. Founded in 1936 with roots in Dallas, Texas, and headquartered in Houston, Texas, the company, incorporated as a Netherlands limited liability company, maintains approximately 3,200 employees. In 2025, Core Laboratories completed the acquisition of Brazil-based Solintec, an integrated geological services provider, for an initial $2.3 million plus potential earnout of up to $3.7 million to expand in-country capabilities for pre-salt offshore and onshore projects along the South Atlantic Margin.
Earnings Preview: Core Laboratories (CLB) Q2 Earnings Expected to Decline
Core Stock Down 39% in 6 Months: Should You Hold or Sell Now?
CORE LABORATORIES ANNOUNCES TIMING OF SECOND QUARTER 2026 EARNINGS RELEASE AND CONFERENCE CALL
Core Lab Stock Plunges 18% in 3 Months: Time to Hold or Fold?
Arista Introduces Next-Generation 1.6Terabit Portfolio for AI Fabrics
Core Laboratories (CLB) Down 4.9% Since Last Earnings Report: Can It Rebound?
Implied Volatility Surging for Core Laboratories Stock Options
Core Laboratories Q1 Earnings Meet Estimates, Decline Y/Y
Core Laboratories Inc. (CLB) Q1 2026 Earnings Call Transcript
CORE LAB REPORTS FIRST QUARTER 2026 RESULTS
DTI or CLB: Which Is the Better Value Stock Right Now?
Core Laboratories to Post Q1 Earnings: Key Metrics to Watch
Earnings Preview: Core Laboratories (CLB) Q1 Earnings Expected to Decline
DTI vs. CLB: Which Stock Is the Better Value Option?
DTI vs. CLB: Which Stock Should Value Investors Buy Now?
Middle East Conflict Weighs On Core Laboratories' Q1 Outlook
Here's Why Hold Strategy Is Apt for Core Laboratories Stock for Now
CORE LAB ANNOUNCES IMPACT OF THE MIDDLE EAST CONFLICT TO FIRST QUARTER 2026 GUIDANCE
Core Laboratories (NYSE:CLB) Shares Cross Above Two Hundred Day Moving Average – Time to Sell?
DTI or CLB: Which Is the Better Value Stock Right Now?